Also from this source

You just read:

Glenmark Announces the Discovery and Initiation of IND Enabling Studies of a Novel Biologics Entity, GBR 401, Targeting Lymphomas and Leukemia's of B-Cell Origin

News provided by

Glenmark Pharmaceuticals Ltd.

Mar 31, 2011, 08:27 ET